Tumor markers are substances (proteins, DNA changes) made by cancer cells or the body in response to cancer, found in blood, urine, or tissue, used to monitor treatment, check for recurrence, and help stage cancer, though not typically for initial diagnosis due to non-cancerous conditions causing similar levels. Key examples include PSA (prostate), CA 125 (ovarian), CEA (colon), and AFP (testicular/liver), but markers like CA 19-9 (pancreatic/biliary) and CA 15-3 (breast) are also used.
During normal pregnancy, tumor markers including CA 15.3, squamous cell carcinoma antigen and CA 125 can be elevated; inhibin B, anti-Müllerian hormone and lactate dehydrogenase levels remain below normal cut-off values.
High tumor marker results could suggest the presence of cancer. It may also suggest that cancer has progressed or spread (metastasized). But this test alone isn't enough to diagnose cancer. If you have high test results, your healthcare provider will explain what the numbers mean.
Very high CA 19-9 levels above 1000 units/mL may indicate an advanced tumor. In monitoring treatment response, the doctor will test the level of CA 19-9 in the blood every 1-3 months during treatment. A fall of CA 19-9 levels could mean that the tumor is responding well to treatment.
Step 2: Schedule a Follow-Up Appointment
During this visit, your healthcare provider may review your full blood work, recommend further testing, or refer you to a specialist. Additional investigations may include: Imaging tests such as ultrasound, CT scan, or MRI. Repeat cancer marker tests to confirm trends.
Once cancer has been diagnosed and treatment is underway, cancer marker tests are used to monitor the effectiveness of treatment. A drop in the levels of cancer markers suggests that the treatment is working, while a rise in levels may indicate that the cancer is progressing or returning.
Tests to find chemicals made by cancer cells.
And some conditions that aren't cancer can cause high levels of tumor markers. Instead, tumor marker tests are mostly used after your cancer diagnosis to see if treatment is working.
Common Tumor Markers and Their Associated Cancers
PSA (Prostate Specific Antigen) assist in the recognition of prostate cancer. CA-125 is engaged to monitor ovarian cancer. CEA (Carcinoembryonic Antigen) is related with colon and rectal cancer and is present in diagnosis as well as for monitoring treatment.
Some of the more useful tumor markers include:
Gynecologic cancer is a disease in which cells in a woman's reproductive organs grow out of control. The five main types of gynecologic cancer are: cervical, ovarian, uterine, vaginal, and vulvar. (A sixth type of gynecologic cancer is the very rare fallopian tube cancer.)
Transient tumor marker elevations caused by chemotherapy were defined as 'Flare' and have been demonstrated in some solid tumors.
Eventually, a CA 125 level of 35 units was found to be a useful cutoff point, with 99% of healthy women having values less than 35. Levels above 35 units are certainly seen in healthy women, but beyond the cutoff point of 35, the higher the value, the more likely there is trouble somewhere in the body.
Signs of Cancer
The 10 deadliest cancers, and why there's no cure
The Galleri test: This specific type of blood test can detect over 50 different types of cancer. It uses DNA sequencing to find unique patterns, which may tell your provider whether you have cancer and where it started.
Common cancer tumor markers include PSA (the prostate-specific antigen); CA 15-3 and CA 27-29 for breast cancer; CA 19-9 for pancreatic cancer; BTA (bladder tumor antigen) for kidney, bladder or ureter cancer; BCR-ABL for leukemia and lymphomas and CEA, or carcinoembryonic antigen, for colorectal cancer.
These are intermediate grade tumors. Grade 3: Cancer cells and tissue look very abnormal. These cancers are considered poorly differentiated, since they no longer have an architectural structure or pattern. Grade 3 tumors are considered high grade.
Complex Reference Range:Male 0-2.0 IU/L. Female 0-1.0 IU/L. hCG up to 7 IU/L have been reported in post menopausal females. Tumour markers are not diagnostic and are of most use in monitoring response to treatment and early detection of relapse. Normal values do NOT exclude malignancy.
A tumor marker is anything present in or produced by cancer cells or other cells of the body in response to cancer or certain benign (noncancerous) conditions that provides information about a cancer, such as how aggressive it is, what kind of treatment it may respond to, or whether it is responding to treatment.
The blood tests recommended depend on the type of cancer. Some of these tests can be rarer, as for certain types of immunoglobulins and tumor markers. Results of these tests can take days to a week or more before results are available.
Tumor marker tests that are used to screen for cancer can't diagnose cancer. If you have a high level of tumor markers, it only means that you're more likely to have cancer. A biopsy is usually needed to diagnose or rule out cancer. Tumor marker tests that use cells from a tumor may help diagnose cancer.
Tumor markers are not always present in early-stage cancers. Tumor markers can be present because of noncancerous conditions. People with cancer may never have elevated tumor markers in their blood. Even when tumor marker levels are high, they are not specific enough to confirm the presence of cancer.
(MAR-ker) A diagnostic indication that disease may develop.
Although the characteristics of an ideal tumor marker depend to some degree on the classification and application of the marker, the general properties of such an ideal tumor marker include (1) specific production by premalignant or malignant tissue early in the progression of disease; (2) produced at detectable levels ...